Oruka Therapeutics, Inc. (ORKA) is listed on NASDAQ in Pharmaceutical Stocks. It is $91.15, -5.58%, with a $6.0B market cap. RSI is 37.5, near oversold. The latest reported quarter missed estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 37.5 Near Oversold
Market Cap $6.0B
Volume 501.6K
Fundamentals — 10-Q Q2 2026
Revenue --
Net Income $-73.0M
EPS --
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Goncalves Joana | Chief Medical Officer | Sell | 7,000 | $111.84 | $782,882 | 2026 Aug 17 |
| Quinlan Paul T | General Counsel | Sell | 52,000 | $108.49 | $5.6M | 2026 Aug 14 |
| Agarwal Arjun | Senior Vice President, Finance | Sell | 10,000 | $106.66 | $1.1M | 2026 Aug 13 |
| Goncalves Joana | Chief Medical Officer | Sell | 7,000 | $86.28 | $603,938 | 2026 Jul 15 |
| Agarwal Arjun | Senior Vice President, Finance | Sell | 9,999 | $84.63 | $846,180 | 2026 Jul 13 |
| Fairmount Funds Management LLC | Director | Sell | 3,553,410 | $84.43 | $300.0M | 2026 Jul 1 |
| Sandler Laura Lee | Chief Operating Officer | Sell | 5,000 | $94.42 | $472,079 | 2026 Jul 1 |
| Agarwal Arjun | Senior Vice President, Finance | Sell | 1,587 | $80.95 | $128,468 | 2026 Jun 22 |
| Agarwal Arjun | Senior Vice President, Finance | Sell | 9,854 | $69.72 | $687,035 | 2026 Jun 15 |
| Goncalves Joana | Chief Medical Officer | Sell | 7,947 | $69.28 | $550,607 | 2026 Jun 15 |
| Klein Lawrence Otto | Chief Executive Officer | Sell | 1,729 | $69.69 | $120,494 | 2026 Jun 15 |
| Sandler Laura Lee | Chief Operating Officer | Sell | 600 | $69.69 | $41,814 | 2026 Jun 15 |
| Quinlan Paul T | General Counsel | Sell | 733 | $69.69 | $51,083 | 2026 Jun 15 |
| Dambkowski Carl | Director | Sell | 35,000 | $70.13 | $2.5M | 2026 Jun 12 |
| Dambkowski Carl | Director | Sell | 105,000 | $58.97 | $6.2M | 2026 May 21 |
| Agarwal Arjun | Senior Vice President, Finance | Sell | 10,290 | $59.07 | $607,806 | 2026 May 18 |
| Goncalves Joana | Chief Medical Officer | Sell | 7,000 | $61.85 | $432,935 | 2026 May 15 |
| Sandler Laura Lee | Chief Operating Officer | Sell | 5,000 | $63.88 | $319,384 | 2026 May 1 |
| Goncalves Joana | Chief Medical Officer | Sell | 7,000 | $66.12 | $462,830 | 2026 Apr 15 |
| Klein Lawrence Otto | Chief Executive Officer | Sell | 1,729 | $41.30 | $71,408 | 2026 Mar 16 |
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
| | $144.22 | 47.1 | $9.3B |
| | $34.67 | 38.7 | $6.0B |
| | $280.77 | 42.4 | $5.6B |
| | $70.09 | 38.5 | $5.8B |
Take ORKA further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put ORKA in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Oruka Therapeutics, Inc. next reports.
Set alerts on ORKA
Get notified when Oruka Therapeutics, Inc. hits your price targets or technical conditions are met.
Get Started Free